Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-risk Myelodysplastic Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Large-scale testing (Phase 3)Not Yet RecruitingNCT07722988
What this trial is testing

Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Kyntra Bio 201
Testing effectiveness (Phase 2)WithdrawnNCT00816413
What this trial is testing

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT00839982
What this trial is testing

Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Fred Hutchinson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT01584531
What this trial is testing

Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeMDSTrisomy 8
Traws Pharma, Inc. 82
Large-scale testing (Phase 3)Study completedNCT01381809
What this trial is testing

An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Janssen-Cilag International NV 130
Testing effectiveness (Phase 2)Ended earlyNCT00074490
What this trial is testing

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

Who this might be right for
LymphomaLeukemiaMyeloproliferative Disorders+2 more
National Cancer Institute (NCI) 442
Large-scale testing (Phase 3)UnknownNCT04216355
What this trial is testing

Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT

Who this might be right for
MDS-EB
Fujian Medical University 20
Testing effectiveness (Phase 2)Study completedNCT01904682
What this trial is testing

Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs

Who this might be right for
Myelodysplastic Syndromes
Traws Pharma, Inc. 45
Testing effectiveness (Phase 2)WithdrawnNCT00085449
What this trial is testing

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT01891968
What this trial is testing

Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00809185
What this trial is testing

RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Case Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Temporarily pausedNCT06630221
What this trial is testing

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic Leukemia
Abhay Singh, MD MPH 25
Testing effectiveness (Phase 2)Study completedNCT00418665
What this trial is testing

A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid

Who this might be right for
Myelodysplastic SyndromesThrombocytopenia
Amgen 39
Testing effectiveness (Phase 2)Study completedNCT01892371
What this trial is testing

Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
FLT3 Gene Mutation NegativeFLT3 Internal Tandem Duplication PositiveRecurrent Acute Myeloid Leukemia+5 more
M.D. Anderson Cancer Center 73
Post-approval studies (Phase 4)Study completedNCT00481143
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload

Who this might be right for
Myelodysplastic SyndromesTransfusion Dependent Iron Overload
Novartis Pharmaceuticals 63
Testing effectiveness (Phase 2)Ended earlyNCT05237713
What this trial is testing

Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients

Who this might be right for
AnemiaMyelodysplastic Syndromes
University of Leipzig 10
Testing effectiveness (Phase 2)WithdrawnNCT07387354
What this trial is testing

Pacritinib With Aza for Upfront Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesMDSMyelodysplastic Syndrome, Unclassifiable+3 more
Thomas Jefferson University
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Testing effectiveness (Phase 2)Study completedNCT00074074
What this trial is testing

Infliximab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 46
Next Page